Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Atogepant (Qulipta®) for migraine prevention.

< BACK TO ARCHIVE


Papers: 23 Apr 2022 - 29 Apr 2022


2022 Apr 22


Trends Pharmacol Sci


http://www.ncbi.nlm.nih.gov/pubmed/35469689?dopt=Abstract

Atogepant (Qulipta®) for migraine prevention.

Authors

Atogepant (Qulipta®) for migraine prevention.
Hay DL, Walker CS, Harris PWR
Trends Pharmacol Sci. 2022 Apr 22.
PMID: 35469689.
Read This Paper